Survivin expression correlates with unfavourable prognoses in invasive ductal carcinoma of the breast

Medical Journal of Malaysia

Volumn 62, Issue 1, 2007, Pages 6-8

  Al Joudi, Fawwaz Shakir ^a,c   Iskandar, Z A ^a   Imran, A K ^b  

^a SCHOOL OF HEALTH SCIENCES   (Malaysia)

^b General Hospital Kota Bharu   (Malaysia)

^c UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

Author keywords

Invasive ductal carcinoma; Prognosis; Survivin expression

Indexed keywords

PROTEIN P53; SURVIVIN;

ARTICLE; BREAST CARCINOMA; CANCER SURVIVAL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; LYMPH NODE; PATIENT ASSESSMENT; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL RATE; TUMOR GROWTH;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; MEDICAL AUDIT; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; PROGNOSIS;

EID: 34447117616     PISSN: 03005283     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Verdecia MA, Huang HK, Dutil E, Kaiser DA, Hunter T, Noel JP Structure of the human anti-apoptotic protein survivin reveals a dimeric arrangement. Nature Structural Biology 2000; 7 (7): 602-8.
2. Altieri DC. The molecular basis and potential role of survivin in cancer diagnosis and therapy. Trends in Molecular Medicine 2001; 7 (12): 542-47.
3. Zaffaroni, N. and Daidone MG. Survivin expression and resistance to anticancer treatments: perspectives for new therapeutic interventions. Drug Resistance Updates 2002; 5: 65-72.
4. Altieri DC and Marchisio C. Survivin apoptosis: An interloper between cell death and cell proliferation in cancer. Lab Invest 1999; 79: 1327-33.
5. Ikehara M, Oshita F, Kameda Y, et al. Expression of survivin correlated with vessel invasion is a marker of poor prognosis in small adenocarcinoma of the lung. Oncol Rep 2002; 9 (4): 835-38.
6. Wurl P, Kappler M Meye A, et al. Co-expression of survivin and TERT and risk of tumor-related death in patients with soft-tissue sarcoma. Lancet 2002; 360 (9336): 877.
7. Kim HS, Shiraki K, Park SH. Expression of survivin in CIN and invasive squamous cell carcinoma of uterine cervix. Anticancer Res 2002; 22 (2A): 805-08.
8. Kennedy SM, O'Driscoll L, Purcell R, et al. Prognostic importance of survivin in breast cancer. Brit J of Cancer 2003; 88 (7): 1077-83.
9. Son BH, Choi JS, Lee JH. Prognostic values of KAI1 and survivin expression in an infiltrating ductal carcinoma of the breast. Pathology 2005; 7(2): 131-6.
10. Altura RA, Olshefski RS, Jiang Y, Boue DR. Nuclear expression of survivin in paediatric ependynomas and choroids plexus tumours correlates with morphology tumour grade. Brit J Cancer 2003; 89 (9): 1743-49.
11. Al-Joudi FS, Iskandar ZA, Samsudin AR. The effects of chemotherapeutic drugs on the viability, apoptosis and survivin expression in MCF-7 cells. Acta Histochem Cytochem 2005; 38 (5): 323-30.
12. Tanaka K, Iwamoto S, Gon G, Nohara T, Iwamoto M, Tanigawa N. Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clinical Cancer Research 2000; 6: 127-34.
13. Rodriguez JA, Span SW, Ferreira CGM, Kruyt FAE, Giaccone G. CRM1-mediated nuclear export determines the cytoplasmic localisation of the antiapoptotic protein survivin. Experimental Cell Research 2002; 275: 44-53.
14. Hayes DF. Designing tumor marker studies: will the results provide clinically useful. Archives of Pathology & Laboratory Medicine 2000; 124 (7): 952-55.
15. Mega S, Miyamoto M, Li L, et al. Immunohistochemical analysis of nuclear survivin expression in esophageal squamous cell carcinoma. Dis Esophagus 2006; 19 (5): 355-9.
16. O'Connor DS, Schechner JS, Adida C, et al. Control of apoptosis during angiogenesis bv survivin expression in endothelial cells. Am J Pathol 2000; 156: 393-98.
17. Al-Joudi FS, Iskandar ZA, Imran AK, et al. Expression of survivin and its clinicopathological correlations in invasive ductal carcinoma of the breast: a study in The North-East of Malaysia. Singapore Med J (In press).
18. Hasnan J and Siti NMN. Clinicopathological features of breast cancer in Kelantan. 9th National Conference on Medical Sciences. 22-23 May 2004, School of Medical Sciences, Universiti Sains Malaysia.
19. Ryan BM, Konecny GE, Kahlert S, et al. Survivin expression in breast cancer predicts clinical outcome and associated with HER2, VEGF, urokinase plasminogen activator and PAI-1. Ann Oncol 2006; 17 (4): 597-604.
20. Span PN, Tjan-Heijnen VC, Manders P, et al. High survivin predicts a poor response to endocrine therapy, but a good response to chemotherapy in advanced breast cancer. Breast Cancer Res Treat 2006; 2: 223-30.
21. Zhu H, Liu S, Zhou C, et al. Anti-apoptosis gene survivin promotes cell growth and transformation. Zhonghua Yi Xue Za Zhi 2002; 82 (5): 338-40.
22. Kennedy SM, O'Driscoll L, Purcell R, et al. Prognostic importance of survivin in breast cancer. Brit J Cancer 2003; 88 (7): 1077-83.